Fatty Liver  >>  pioglitazone  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT01431521: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)

Completed
1
31
NA
MK-4074 200 mg, Placebo for MK-4074, Pioglitazone hydrochloride 30 mg, Placebo for pioglitazone hydrochloride
Merck Sharp & Dohme LLC
Non-alcoholic Fatty Liver Disease
09/12
10/12

Download Options